Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank20
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-49.45M
↓ 33% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-37.13M
Historical baseline
PeriodValueYoY Change
TTM$-49.45M+2.7%
2024$-50.85M-10.0%
2023$-46.20M-54.6%
2022$-29.88M-51.7%
2021$-19.70M+26.3%
2020$-26.72M-